Supramolecular organization of S12363-liposomes prepared with two different remote loading processes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 5, 2009, Pages 926-935

  Chemin, Caroline ^a,b   Péan, Jean Manuel ^b   Bourgaux, Claudie ^a   Pabst, Georg ^c   Wüthrich, Patrick ^b   Couvreur, Patrick ^a   Ollivon, Michel ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c Institute of Biophysics and Nanosystems Research   (Austria)

Author keywords

Active loading process; Anticancer drug; Differential scanning calorimetry; Liposome; Spectrofluorimetry; X ray diffraction

Indexed keywords

AMMONIA; AMMONIUM SULFATE; ANTINEOPLASTIC AGENT; CHOLESTEROL; DRUG CARRIER; LIPOSOME; MACROGOL; S 12363; SPHINGOMYELIN; UNCLASSIFIED DRUG; WATER;

ACIDITY; ACTIVE TRANSPORT; ARTICLE; BILAYER MEMBRANE; COMPARTMENT MODEL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CAPSULE; DRUG FORMULATION; DRUG STABILITY; DRUG UPTAKE; ENCAPSULATION; ENERGY YIELD; INTERFACE PRESSURE; INTERPHASE; LIPID MEMBRANE; LIPOSOMAL DELIVERY; MOLECULAR STABILITY; PARTITION CHROMATOGRAPHY; PH MEASUREMENT; PHYSICAL CHEMISTRY; POLARIZATION; PRIORITY JOURNAL; REACTION TIME; SPECTROFLUOROMETRY; SUPRAMOLECULAR CHEMISTRY; SYNCHROTRON; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 65249150274     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.11.017     Document Type: Article

References (33)

1. Gregoriadis G., Wills E.J., Swain C.P., and Tavill A.S. Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1 (1974) 1313-1316
2. Lavielle G., Hautefaye P., Schaeffer C., Boutin J., Cudennec C., and Pierre A. New alpha-amino phosphonic acid derivatives of vinblastine: chemistry and antitumor activity. J. Med. Chem. 34 (1991) 1998-2003
3. Pierre A., Kraus-Berthier L., Atassi G., Cros S., Poupon M.F., Lavielle G., Berlion M., and Bizzari J.P. Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363. Cancer Res. 51 (1991) 2312-2318
4. Lasic D.D. Liposomes: From Physics to Applications (1993), London
5. Chonn A., and Cullis P.R. Recent advances in liposomal drug delivery systems. Curr. Opin. Biotechnol. 6 (1995) 698-708
6. Mayer L.D., Madden T.D., Bally M.B., and Cullis P.R. pH Gradient-Mediated Drug Entrapment in Liposome, Vol. 2 (1993), CRC Press, Boca Raton, FL
7. Maurer-Spurej E., Wong K.F., Maurer N., Fenske D.B., and Cullis P.R. Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients. Biochim. Biophys. Acta 1416 (1999) 1-10
8. Needham D., and Nunn R.S. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys. J. 58 (1990) 997-1009
9. Mouritsen O.G., and Jorgensen K. Dynamical order and disorder in lipid bilayers. Chem. Phys. Lipids 73 (1994) 3-25
10. Mouritsen O.G., and Jorgensen K. A new look at lipid-membrane structure in relation to drug research. Pharm. Res. 15 (1998) 1507-1519
11. M.S. Webb, M.B. Bally, L.D. Mayer, J.J. Miller, P.G. Gardi. Vol. 05, pp. 335, Inex Pharmaceuticals Corporation, U.S. 1998.
12. Semple S.C., Leone R., Wang J., Leng E.C., Klimuk S.K., Eisenhardt M.L., Yuang Z.-N., Edwards K., Maurer N., Hope M.J., Cullis P.R., and Ahkong Q.F. Optimization and characterization of sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. J. Pharm. Sci. 94 (2005) 1024-1038
13. Amselem S., Cohen R., and Barenholz Y. In vitro tests to predict in vivo performance of liposomal dosage forms. Chem. Phys. Lipids 64 (1993) 219-237
14. Charrois G.J.R., and Allen T.M. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim. Biophys. Acta (BBA) - Biomembranes 1663 (2004) 167-177
15. Flaten G.E., Skar M., Luthman K., and Brandl M. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability. Eur. J. Pharm Sci. 30 (2007) 324-332
16. Kyrikou I., Daliani I., Mavromoustakos T., Maswadeh H., Demetzos C., Hatziantoniou S., Giatrellis S., and Nounesis G. The modulation of thermal properties of vinblastine by cholesterol in membrane bilayers. Biochim. Biophys. Acta 1661 (2004) 1-8
17. Nicholov R., DiTizio V., and DiCosmo F. Interaction of paclitaxel with phospholipid bilayers. J. Liposome Res. 5 (1995) 503-522
18. 2H-NMR study. Biochim. Biophys. Acta 901 (1987) 191-200
19. Grabielle-Madelmont C., Hochapfel A., and Ollivon M. Antibiotic-phospholipid interactions as studied by DSC and X-ray diffraction. J. Phys. Chem 103 (1999) 4534-4548
20. Lin H.-J., Szmacinski H., and Lakowicz J.R. Lifetime-based pH sensors: indicators for acidic environments. Anal. Biochem. 269 (1999) 162-167
21. Grabielle-Madelmont C., and Perron R. Calorimetric studies on phospholipids-water systems. I. dl-dipalmitoylphosphatidylcholine (DPPC)-water system. J. Colloid Interface Sci. 95 (1983) 471-482
22. Keller G., Lavigne F., Forte L., Andrieux K., Dahim M., Loisel C., Ollivon M., Bourgaux C., and Lesieur P. DSC and X-ray diffraction coupling specifications and applications. J. Therm. Anal. Calorim. 51 (1998) 783-791
23. Lavigne F., Bourgaux C., and Ollivon M. Phase transitions of saturated triglycerides. J. Phys. IV 3 (1993) 137-140
24. Pabst G., Rappolt M., Amenitsch H., and Laggner P. Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality X-ray data. Phys. Rev. E 62 (2000) 4000-4009
25. Pabst G., Koschuch R., Pozo-Navas B., Rappolt M., Lohner K., and Laggner P. Structural analysis of weakly ordered membrane stacks. J. Appl. Cryst. 36 (2003) 1378-1388
26. Pabst G. Global properties of biomimetic membranes: perspectives on molecular features. Biophys. Rev. Lett. 1 (2006) 57-84
27. Hope M.J., Bally M.B., Webb G., and Cullis P.R. Production of large unilamellar vesicule by a rapid extrusion procedure. Characterisation of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812 (1985) 55-65
28. Cullis P.R., Hope M.J., Bally M.B., Madden T.D., Mayer L.D., and Janoff A.S. Liposomes as pharmaceuticals. In: Ostro M.J. (Ed). Liposomes From Biophysics to Therapeutics (1987), Marcel Dekker, New York 39-72
29. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., and Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochim. Biophys. Acta (BBA) - Biomembranes 1239 (1995) 145-156
30. Abraham S.A., Edwards K., Karlsson G., Hudon N., Mayer L.D., and Bally M.B. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. J. Control. Release 96 (2004) 449-461
31. Zhigaltsev I.V., Maurer N., Akhong Q.-F., Leone R., Leng E., Wang J., Semple S.C., and Cullis P.R. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J. Control. Release 104 (2005) 103-111
32. Chemin C., Bourgaux C., Péan J.-M., Pabst G., Wüthrich P., Couvreur P., and Ollivon M. Consequences of ions and pH on the supramolecular organization of sphingomyelin and sphingomyelin/cholesterol bilayers. Chem. Phys. Lipids 153 (2008) 119-129
33. Maswadeh H., Demetzos C., Daliani I., Kyrikou I., Mavromoustakos T., Tsortos A., and Nounesis G. A molecular basis explanation of the dynamic and thermal effects of vinblastine sulfate upon dipalmitoylphosphatidylcholine bilayer membranes. Biochim.Biophys. Acta (BBA) - Biomembranes 1567 (2002) 49-55